Prochlorperazine vs Imitrex for Acute Migraine in the Emergency Department
NCT ID: NCT00573599
Last Updated: 2025-08-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2007-02-28
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Buccal Prochlorperazine Versus Intravenous Prochlorperazine for Migraine Headaches, a RCT
NCT02779959
Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine
NCT01629329
Randomized Evaluation of Octreotide Versus Compazine for Emergency Department Treatment of Migraine Headache
NCT00274170
Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room
NCT04726592
Intravenous Fluids in Benign Headaches Trial
NCT03185130
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
prochlorperazine and benadryl IV, saline subQ
prochlorperazine and benadryl IV
prochlorperazine and benadryl IV, saline subQ
2
imitrex SubQ, saline IV
Imitrex SubQ, saline IV
Imitrex SubQ, saline IV
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prochlorperazine and benadryl IV
prochlorperazine and benadryl IV, saline subQ
Imitrex SubQ, saline IV
Imitrex SubQ, saline IV
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Hypertension
* Chest pain
* \< 18
* Allergy to any of the meds
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Naval Medical Center, Portsmouth
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frank Gutierrez, MD
Role: PRINCIPAL_INVESTIGATOR
US Navy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naval Medical Center Portsmouth
Portsmouth, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P06-050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.